Home » Takeda’s Drug Vedolizumab Is Granted Priority Review Status By FDA
Takeda’s Drug Vedolizumab Is Granted Priority Review Status By FDA
Takeda has received FDA priority review status for its BLA for vedolizumab, a drug that aims at treating ulcerative colitis in adults.
PharmTech.com
PharmTech.com
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May